If left undiagnosed and untreated for a prolonged period, fatty liver disease can progress to more serious conditions, such as cirrhosis and liver cancer.
All over the United States, countless research projects designed to improve outcomes have lost funding or been shut down. Even screening efforts targeting patients in impoverished communities have been impacted by these policies.
The first 250 patients has been enrolled in the CORCINCH-HF U.S. pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System in patients with HFrEF.
Might mammography enhanced by contrast media prove a surer, faster way than other modalities—including digital breast tomosynthesis—to get to a definitive diagnosis for women with dense breast tissue? The American College of Radiology wants to know.
Reviewing data from more than 23.5 million U.S. patients, the study's authors found that methamphetamine use was linked to a whopping 86% increase in a patient's AFib risk. The other substances included in the analysis were not far behind.
The adult brain may be more malleable than scientists previously thought, according to new research presented at the 35th European College of Neuropsychopharmacology.
Children are at heightened risk of major clinical depression when at least one parent has a history of the disorder. New research shows depression markers appearing on structural and functional brain MRI ahead of symptoms in these “familial risk” offspring from infancy through early adulthood.
A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib.
Nearly 30% of corresponding authors included in the analysis shared that they had witnessed scientific fraud in their department within the last five years.
